Its chilly and most importantly its dry This dryness is leading to skin conditions and other season-related issues-- contact ...

The U.S. Food and Drug Administration has approved Organon's Vtama (tapinarof) 1% cream for an additional indication -- the ...

The FDA approved tapinarof cream 1% (Vtama) for eczema in individuals ages 2 years and older, drugmaker Organon announced on ...

Armpit rashes can appear in different ways ... such as the underarms. Atopic dermatitis, also known as eczema, can affect the armpits. It happens when a problem with the skin barrier makes ...

The U.S. Food and Drug Administration has approved Galderma's Nemluvio (nemolizumab) for the treatment of moderate-to-severe atopic dermatitis in patients aged 12 years and older.

The FDA has approved Vtama® (tapinarof) cream 1% for the topical treatment of atopic dermatitis in patients aged 2 years and older.

Corvus Pharmaceuticals develops next-gen ITK inhibitors, with promising Phase 1 results. Read why CRVS stock can thrive in ...

MedlinePlus. Rash evaluation. Consumer Reports. Prevent chafing, blisters, and other summer skin troubles. Allergy & Asthma Network. Eczema (atopic dermatitis) statistics. National Eczema Association.

Individuals with atopic dermatitis are at a 1.44% increased risk of developing Meniere disease when compared with those without atopic dermatitis.

Atopic dermatitis in infancy is associated with an increased risk of developing subsequent atopic march conditions such as allergy or asthma.

Galderma lists the most common side effects of Nemluvio when used for treating atopic dermatitis as headache, muscle and joint pain, and hives (itchy red rashes). The company advises patients to ...